Pyridoxine hydrochloride [clinicaltrials_resource:425cb253d19c5751d13955269f1c1fed]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000636]Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000638]A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [clinicaltrials:NCT00000778]A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [clinicaltrials:NCT00000796]Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [clinicaltrials:NCT00000950]Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]The Treatment of Tuberculosis in HIV-Infected Patients [clinicaltrials:NCT00001033]
intervention [clinicaltrials_vocabulary:intervention]
Pyridoxine hydrochloride [clinicaltrials_resource:425cb253d19c5751d13955269f1c1fed]
Bio2RDF identifier
425cb253d19c5751d13955269f1c1fed
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:425cb253d19c5751d13955269f1c1fed
intervention name [clinicaltrials_vocabulary:intervention-name]
Pyridoxine hydrochloride
identifier
clinicaltrials_resource:425cb253d19c5751d13955269f1c1fed
title
Pyridoxine hydrochloride
@en
type
label
Pyridoxine hydrochloride [clinicaltrials_resource:425cb253d19c5751d13955269f1c1fed]
@en